Consignment of sedative from India seized in US

August 13, 2013 09:33 am | Updated 09:33 am IST - Washington

The American and German police have announced seizure of a huge consignment of a sedative-hypnotic medicine associated with a high risk of death and cancer, coming from India.

In collaboration with the German Customs Investigations Bureau, Zollkriminalamt, US Customs and Border Protection (CBP) announced that as many as 20,000 Zolpidem pills were seized at the San Francisco International Mail Facility in several parcels originating from India.

Upon closer examination of the suspect parcels, CBP personnel discovered that the 10 parcels contained a total of 20,000 Zolpidem pills, a Schedule IV controlled substance.

“Timely information from Zollkriminalamt and excellent targeting and coordination efforts by CBP’s Pharmaceuticals Center of Excellence and Expertise resulted in this significant interception, keeping these harmful pills off of our streets,” Robert E Perez, Director of Field Operations in New York said on Monday.

“We thank our partners in German Customs for their ongoing collaboration,” Mr. Perez said.

This enforcement action follows another collaborative enforcement effort in March between CBP and French Customs Fake Medicine Observatory, when CBP personnel seized 400 Carisoprodol pills, another schedule IV controlled substance.

“The Zollkriminalamt intends to pursue this excellent cooperation against growing global threats. We look forward to our continued work together and are confident, that this will not be the last joint operation,” said Dr Ulrike Berg-Haas, German Customs liaison.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.